Dr Anna Perdrix Rosell

Dr. Anna Perdrix Rosell is the Co-CEO and Founder of a prominent organization, holding an MBA alongside her academic qualifications in cancer research. She graduated from King’s College London with an MRes in Translational Cancer Medicine and completed her PhD at the Francis Crick Institute in London. Dr. Rosell’s research has been widely recognized, with publications in esteemed journals such as Current Biology, Cell, and Nature Medicine, and she has been instrumental in filing multiple patent applications. As a principal investigator, she has led over 15 large international collaborative projects. Her achievements in the field of science and healthcare earned her a spot on the Forbes 30 under 30 Science and Healthcare list in 2018. Additionally, Dr. Rosell is an active member of the UK’s Bioindustry Association Engineering Biology and Science and Innovation Advisory Committees, contributing to policy and innovation in biotechnology.